Swiss Biologics CDMO Manufacturers (2026)
Swiss biologics CDMOs anchor a CHF 57.4B immunological export engine. How Lonza, Celonic and specialty players win clients beyond CPHI.
May 2026 11 min read
Swiss biologics CDMOs anchor a CHF 57.4B immunological export engine. How Lonza, Celonic and specialty players win clients beyond CPHI.
The global mAb market hit $286B in 2025. Swiss manufacturers in Basel and Visp produce a large share. Here is how they build pipeline.
Sanofi committed over EUR 2.5B to French biologics. How GTP Bioways, Cenexi and peers win mAb and biosimilar contracts beyond CPHI.
US biologics manufacturers sit on a $200B+ domestic market but still chase international buyers through trade shows and field reps.